Article
Emerging biosimilars market presents opportunities and challenges
- Author:
- Jane De Lartigue, PhD
Article
Paradigm-changing osimertinib approval in front-line for advanced NSCLC
- Author:
- Jane De Lartigue, PhD
Article
BRAF-MEK inhibitor combo approved for adjuvant melanoma therapy
- Author:
- Jane De Lartigue, PhD
Article
Immunotherapy may hold the key to defeating virally associated cancers
- Author:
- Jane De Lartigue, PhD
Article
Game changers in pediatric cancer
- Author:
- Jane De Lartigue, PhD
Article
Addressing the rarity and complexities of sarcomas
- Author:
- Jane De Lartigue, PhD
Article
Tumor heterogeneity: a central foe in the war on cancer
- Author:
- Jane De Lartigue, PhD
Article
Expanding treatment options for diverse neuroendocrine tumors
- Author:
- Jane De Lartigue, PhD
Article
Hallmark tumor metabolism becomes a validated therapeutic target
- Author:
- Jane De Lartigue, PhD
Article
Targeted therapies forge ahead in multiple breast cancer subtypes
- Author:
- Jane De Lartigue, PhD
Article
Pancreatic cancer: a therapeutic challenge yet to be met
- Author:
- Jane De Lartigue, PhD
Article
Slow and steady progress in managing gynecologic cancer
- Author:
- Jane De Lartigue, PhD